PANews reported on January 20th that, according to CoinDesk, publicly listed blockchain infrastructure company TenX Protocols has entered into a strategic stakingPANews reported on January 20th that, according to CoinDesk, publicly listed blockchain infrastructure company TenX Protocols has entered into a strategic staking

TenX adds Tezos to its crypto asset reserve, buying 5.5 million XTZ and targeting staking yields.

2026/01/20 23:44

PANews reported on January 20th that, according to CoinDesk, publicly listed blockchain infrastructure company TenX Protocols has entered into a strategic staking partnership with the Tezos Foundation, purchasing approximately 5.5 million XTZ tokens for about $3.25 million. The company purchased XTZ between January 2nd and 19th through open market and over-the-counter trading at an average price of $0.5868, funded by a funding round completed in August 2025.

TenX plans to stake these tokens through its own validator nodes, targeting an annualized yield (before costs) of approximately 8% to 10%, with the rewards reflected in its publicly available financial reports. As part of the collaboration, the Tezos Foundation also plans to delegate a portion of its XTZ holdings to validator nodes operated by TenX. TenX emphasizes that the delegation only involves staking and does not include governance control; the company will vote independently on Tezos upgrades.

Market Opportunity
Tezos Logo
Tezos Price(XTZ)
$0.5737
$0.5737$0.5737
+0.05%
USD
Tezos (XTZ) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.